ICD-10-CM Billable Code

C69.5

Malignant neoplasm of lacrimal gland and duct

Clinical Classification Guidelines

Inclusion Terms

  • Malignant neoplasm of lacrimal sac
  • Malignant neoplasm of nasolacrimal duct

Medical Intelligence & Overview

Malignant neoplasm of the lacrimal gland and duct, classified under ICD-10 code C69.5, refers to a type of eye tumor that originates in the tear-producing structures of the eye. This condition involves cancerous growths in the lacrimal gland, which is responsible for producing tears, or in the nasolacrimal duct, the passage through which tears drain from the eye into the nose. Though rare, these malignancies require prompt medical attention due to their potential to grow and spread within the eye region.

Causes & Symptoms

Clinical Causes: Genetic mutations that lead to abnormal cell growth Chronic inflammation or injury in the eye area Exposure to environmental carcinogens such as radiation or chemicals Previous history of cancer elsewhere increasing the risk Unknown factors in many cases, as specific causes are not well established

Key Symptoms: Persistent swelling or a noticeable lump near the eye or eyelid Decreased or blurry vision Unexplained pain or discomfort around the eye Redness or irritation of the eye Discharge from the eye or tearing issues Photophobia (sensitivity to light) In some cases, visible growth or abnormality around the eye

Diagnostic & Treatment

Diagnosis Path: Diagnosing malignant neoplasms of the lacrimal gland and duct involves a comprehensive eye examination and additional testing, including: - Imaging Studies: Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scans to evaluate the tumor's size and extent - Biopsy: A tissue sample taken from the suspected area for histopathological analysis to confirm malignancy - Specialist Consultation: Referral to an ophthalmologist or ocular oncologist experienced in eye tumors Early diagnosis is essential to manage the condition effectively and determine the appropriate course of treatment.

Treatment Protocols: Treatment options typically involve a multidisciplinary approach tailored to the tumor's size, location, and spread, and may include: - Surgery: Removal of the tumor, which may involve excision of part or all of the lacrimal gland or duct, and in some cases, more extensive surgical procedures - Radiation Therapy: Targeted radiation to destroy cancer cells or shrink tumors, often used as an adjunct to surgery - Chemotherapy: Systemic or localized chemotherapy may be considered, especially in cases of metastasis - Follow-up Care: Regular monitoring through imaging and examinations to detect any recurrence or spread Prognosis depends on various factors, including how early the cancer is detected and how thoroughly it is treated.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C69.5 a billable ICD-10 code?
Yes, C69.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C69.5?
Clinical documentation must specify the nature of Malignant neoplasm of lacrimal gland and duct and any associated comorbidities for accurate reporting.

Cite this Clinical Reference